Skip to main content

Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations

The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.